Perkins Coie Trust Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.76M Sell
18,907
-247
-1% -$53.1K 0.79% 34
2026
Q1
$4.17M Sell
19,154
-313
-2% -$69.4K 0.8% 36
2025
Q4
$4.45M Sell
19,467
-659
-3% -$150K 0.83% 33
2025
Q3
$4.66M Buy
20,126
+705
+4% +$144K 0.88% 32
2025
Q2
$3.6M Sell
19,421
-257
-1% -$47.8K 0.61% 44
2025
Q1
$4.12M Sell
19,678
-582
-3% -$113K 0.94% 35
2024
Q4
$3.6M Sell
20,260
-375
-2% -$68.9K 0.79% 41
2024
Q3
$4.07M Sell
20,635
-179
-0.9% -$33.4K 0.9% 37
2024
Q2
$3.57M Sell
20,814
-2,822
-12% -$467K 0.83% 40
2024
Q1
$4.3M Sell
23,636
-831
-3% -$143K 1.01% 34
2023
Q4
$3.79M Sell
24,467
-1,448
-6% -$211K 0.96% 34
2023
Q3
$3.86M Sell
25,915
-327
-1% -$48K 1.09% 28
2023
Q2
$3.54M Sell
26,242
-827
-3% -$121K 1% 33
2023
Q1
$4.31M Buy
27,069
+595
+2% +$91K 1.29% 25
2022
Q4
$4.28M Sell
26,474
-605
-2% -$92.8K 1.37% 24
2022
Q3
$3.63M Buy
27,079
+144
+0.5% +$20.7K 1.39% 26
2022
Q2
$4.13M Sell
26,935
-188
-0.7% -$28.7K 1.5% 22
2022
Q1
$4.4M Sell
27,123
-106
-0.4% -$15.4K 1.37% 29
2021
Q4
$3.69M Buy
27,229
+1,373
+5% +$162K 1.08% 37
2021
Q3
$2.79M Sell
25,856
-85
-0.3% -$9.71K 0.87% 44
2021
Q2
$2.92M Buy
25,941
+18
+0.1% +$2.03K 0.9% 44
2021
Q1
$2.81M Sell
25,923
-769
-3% -$82.3K 0.93% 44
2020
Q4
$2.86M Buy
26,692
+506
+2% +$48.6K 0.98% 40
2020
Q3
$2.29M Buy
26,186
+20
+0.1% +$1.88K 0.92% 41
2020
Q2
$2.57M Buy
26,166
+1,219
+5% +$107K 1.06% 35
2020
Q1
$1.9M Buy
24,947
+720
+3% +$61.3K 0.97% 44
2019
Q4
$2.15M Buy
24,227
+1,800
+8% +$149K 0.88% 49
2019
Q3
$1.7M Buy
22,427
+167
+0.8% +$11.4K 0.75% 53
2019
Q2
$1.62M Sell
22,260
-161
-0.7% -$12.7K 0.74% 53
2019
Q1
$1.81M Buy
22,421
+794
+4% +$65K 0.84% 48
2018
Q4
$1.99M Sell
21,627
-414
-2% -$36.4K 1.04% 36
2018
Q3
$2.08M Sell
22,041
-319
-1% -$30.3K 0.97% 40
2018
Q2
$2.07M Sell
22,360
-219
-1% -$21.4K 1.02% 39
2018
Q1
$2.14M Sell
22,579
-639
-3% -$70.2K 1.06% 37
2017
Q4
$2.25M Sell
23,218
-749
-3% -$70.6K 1.12% 33
2017
Q3
$2.13M Buy
23,967
+12
+0.1% +$913 1.11% 35
2017
Q2
$1.74M Buy
23,955
+1,588
+7% +$107K 0.93% 41
2017
Q1
$1.46M Sell
22,367
-96
-0.4% -$6.04K 0.86% 44
2016
Q4
$1.41M Sell
22,463
-262
-1% -$16K 0.85% 48
2016
Q3
$1.43M Buy
22,725
+758
+3% +$49.1K 0.91% 46
2016
Q2
$1.36M Buy
21,967
+673
+3% +$41K 0.9% 45
2016
Q1
$1.22M Sell
21,294
-1,343
-6% -$74.9K 0.83% 49
2015
Q4
$1.34M Buy
22,637
+316
+1% +$18.2K 1.01% 42
2015
Q3
$1.21M Sell
22,321
-62
-0.3% -$4.04K 0.98% 42
2015
Q2
$1.5M Buy
22,383
+239
+1% +$15.6K 1.13% 38
2015
Q1
$1.3M Sell
22,144
-639
-3% -$38.6K 1% 43
2014
Q4
$1.49M Sell
22,783
-178
-0.8% -$11.2K 1.19% 38
2014
Q3
$1.33M Buy
22,961
+113
+0.5% +$6.27K 1.11% 43
2014
Q2
$1.29M Sell
22,848
-17
-0.1% -$892 1.2% 46
2014
Q1
$1.18M Buy
22,865
+447
+2% +$22.6K 1.13% 46
2013
Q4
$1.18M Buy
+22,418
New +$1.1M 1.17% 47

Other funds holding ABBV

Perkins Coie Trust Company's ABBV Position: Q2 2026 in Review

Perkins Coie Trust Company reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $53.1K and leaving 18,907 shares worth $4.76M. The position accounts for 0.79% of the portfolio, ranked #34.

Perkins Coie Trust Company first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Perkins Coie Trust Company held 18,907 shares of AbbVie worth $4.76M as of Q2 2026.
  • Perkins Coie Trust Company sold 247 AbbVie shares in Q2 2026, an estimated $53.1K.
  • AbbVie made up 0.79% of Perkins Coie Trust Company's portfolio in Q2 2026, its #34 holding.
  • Perkins Coie Trust Company first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.